Immune Modulation as Adjunctive Therapy for Pneumocystis pneumonia
2011
Immune Modulation for Pneumocystis Pneumonia
publication
Evidence: moderate
Author Information
Author(s): Wang Jing, Wright Terry W., Gigliotti Francis
Primary Institution: University of Rochester Medical Center
Hypothesis
Can immune modulation improve outcomes for patients with Pneumocystis pneumonia?
Conclusion
Targeting immune responses may enhance treatment outcomes for patients suffering from Pneumocystis pneumonia.
Supporting Evidence
- Pneumocystis pneumonia is a leading cause of death among HIV-infected patients.
- Immune responses play a significant role in the pathogenesis of Pneumocystis pneumonia.
- Modulating immune responses could improve patient outcomes.
Takeaway
This study looks at how the immune system can be adjusted to help people with a serious lung infection called Pneumocystis pneumonia feel better.
Methodology
The review summarizes immunopathogenic mechanisms and discusses potential immune modulation therapies.
Limitations
The study is a review and does not present new experimental data.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website